CCT Research — Papillion, Nebraska

CCT Research is a clinical research site located in Papillion, Nebraska, United States 68046.

Crixeo Clinical Trials Trust Score: 13/100 (FAILING). This profile has not yet been claimed by the site owner.

CCT Research has participated in 3 clinical trials with 1 currently active.

Therapeutic areas: Chronic Migraine, Respiratory Syncytial Virus.

Sponsors: AbbVie, ModernaTX, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Papillion

Browse all research sites in Nebraska · View every site in Papillion

• Midlands Cancer Center at Midlands Community Hospital
• Midlands Community Hospital
• Alegent Health-Midlands Community Hospital
• Alegent Health Midlands Hospital
• GSK Investigational Site
• Research Site
• Novartis Investigative Site
• The Asthma and Allergy Center
• Cognitive Clinical Trials (CCT) - Papillion /ID# 248536
• Asthma & Allergy Center, P.C.
• Investigational Site Number 840004
• The Asthma & Allergy Center, PC

Sponsor Feasibility Report

Trust Score: 13/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for CCT Research?

CCT Research has a Crixeo Trust Score of 13/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has CCT Research conducted?

CCT Research has 3 clinical trials on record, with 1 currently active. Their work covers Chronic Migraine, Respiratory Syncytial Virus.

Is CCT Research accredited by Crixeo Clinical Trials?

CCT Research has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about CCT Research?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.